このエントリーをはてなブックマークに追加
ID 62711
FullText URL
Author
Fujiwara, Noriko Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Watanabe, Mayu Department of Primary Care and Medical Education, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Katayama, Akihiro Diabetes Center, Okayama University Hospital
Noda, Yohei Department of Otolaryngology-Head and Neck Surgery, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Eguchi, Jun Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine Kaken ID researchmap
Kataoka, Hitomi Department of Primary Care and Medical Education, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine
Kagawa, Shunsuke Minimally Invasive Therapy Center, Okayama University Hospital ORCID Kaken ID publons researchmap
Wada, Jun Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine ORCID Kaken ID publons researchmap
Abstract
Immune checkpoint inhibitor-induced diabetes mellitus is a rare immune-related adverse event. This report illustrates clinical data and insulin secretory ability before and after the onset of immune checkpoint inhibitor-induced diabetes.
Keywords
C-peptide
diabetes mellitus
immune checkpoint inhibitor
insulin secretion
Published Date
2021-09-07
Publication Title
Clinical Case Reports
Volume
volume9
Issue
issue9
Publisher
Wiley
Start Page
e04574
ISSN
2050-0904
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2021 The Authors.
File Version
publisher
PubMed ID
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.1002/ccr3.4574
License
https://creativecommons.org/licenses/by-nc-nd/4.0/
Open Access (Publisher)
OA